Open AccessPractical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review
Author(s) -
Waqar Waheed,
Eric A. Newman,
Marwa Aboukhatwa,
Maryam Moin,
Rup Tandan
Publication year - 2022
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s266031
Subject(s) - eculizumab , medicine , myasthenia gravis , tolerability , acetylcholine receptor , immunology , autoantibody , complement system , antibody , neuromuscular transmission , adverse effect , pharmacology , receptor